NHS England Quietly Scrubs Inflated Palantir Adoption Claims as £330M Contract Extension Looms

29 of 137 trusts listed as 'benefiting' from Palantir's NHS data platform weren't actually using it. NHS England deleted the page after the Guardian reported the gap — just as ministers weigh a contract extension to 2029.

NHS England has removed a webpage claiming 137 hospital trusts were "live" with and "realising benefits" from Palantir's AI-powered federated data platform (FDP) after the Guardian revealed that 29 of those trusts said the system was either not live or they were not using any of its applications. The deletion is a quiet admission that the public-facing case for the technology was built on numbers that did not survive basic verification.

The timing is pointed. Ministers are actively weighing whether to extend Palantir's £330m contract to 2029, and the Office for Statistics Regulation (OSR) has opened an examination into the accuracy of NHS England's claims about the platform's reach. This is the second time the OSR has flagged problems: the watchdog previously warned there was no evidence to support NHS England's claim that the FDP had helped deliver more than 100,000 extra operations. The campaign group Medact obtained the underlying data through freedom of information requests to every hospital and integrated care board in England. Their research exposed a gap between institutional marketing and ground-level reality — a pattern that Labour MP Ben Coleman, a member of the Commons health and social care select committee, called "troubling." Coleman warned the overclaiming could actually undermine the platform's viability by putting other hospitals off adoption. Palantir's lobbying operation is running at full intensity. The company has hired Labour peer Tom Watson as a full-time lobbyist, and Watson recently wrote to Health Secretary Yvette Cooper pitching the company as a partner in building "Britain's sovereign technological capability" — a notable framing for a firm founded by Trump-supporting billionaire Peter Thiel that also serves the Israeli military and the US ICE immigration enforcement apparatus. The opposition is broad-based and growing. Unison general secretary Andrea Egan called Palantir a "sinister American surveillance firm" and said extending the deal would be "completely unacceptable and a betrayal of staff and patients." The Doctors Association UK, Amnesty UK, Medact, and Just Treatment have jointly written to the Prime Minister and Cooper opposing even a two-year extension, arguing the contract's built-in "termination assistance period" would allow a safe transition away from Palantir by 2027. Coleman and other critics want the NHS to develop an open platform for health data on which NHS trusts and British tech companies can build tools — a model that would distribute capability rather than concentrate it in a single foreign vendor. The replacement webpage now offers vaguer language about "early users" seeing "reduced admin, faster patient pathways, and more time for care," stripped of the specific trust-by-trust claims that collapsed under scrutiny. NHS England did not respond to requests for comment. The silence itself is informative: an institution that was willing to publish granular claims of success is now unwilling to defend them or explain how they were assembled in the first place.